产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
GLP-26 | G651961-5mg | ≥98% | 2133017-36-2 | 5mg | ¥ 2850.9 | 期货,请咨询 | 阿拉丁 |
GLP-26 | G651961-50mg | ≥98% | 2133017-36-2 | 50mg | ¥ 9800.9 | 期货,请咨询 | 阿拉丁 |
GLP-26 | G651961-25mg | ≥98% | 2133017-36-2 | 25mg | ¥ 5950.9 | 期货,请咨询 | 阿拉丁 |
GLP-26 | G651961-1mg | ≥98% | 2133017-36-2 | 1mg | ¥ 950.9 | 期货,请咨询 | 阿拉丁 |
GLP-26 | G651961-10mg | ≥98% | 2133017-36-2 | 10mg | ¥ 3850.9 | 期货,请咨询 | 阿拉丁 |
GLP-26 | G651961-100mg | ≥98% | 2133017-36-2 | 100mg | ¥ 15800.9 | 期货,请咨询 | 阿拉丁 |
GDC-0425 | G651939-5mg | ≥99% | 1200129-48-1 | 5mg | ¥ 700.9 | 期货,请咨询 | 阿拉丁 |
GDC-0425 | G651939-50mg | ≥99% | 1200129-48-1 | 50mg | ¥ 3800.9 | 期货,请咨询 | 阿拉丁 |
GDC-0425 | G651939-25mg | ≥99% | 1200129-48-1 | 25mg | ¥ 2200.9 | 期货,请咨询 | 阿拉丁 |
GDC-0425 | G651939-10mg | ≥99% | 1200129-48-1 | 10mg | ¥ 1100.9 | 期货,请咨询 | 阿拉丁 |
GDC-0425 | G651939-100mg | ≥99% | 1200129-48-1 | 100mg | ¥ 6000.9 | 期货,请咨询 | 阿拉丁 |
Gefitinib impurity 2 | G651932-5mg | ≥99% | 246512-44-7 | 5mg | ¥ 2500.9 | 期货,请咨询 | 阿拉丁 |
GSK2593074A | G651840-5mg | ≥98% | 1337531-06-2 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
GSK2593074A | G651840-50mg | ≥98% | 1337531-06-2 | 50mg | ¥ 16500.9 | 期货,请咨询 | 阿拉丁 |
GSK2593074A | G651840-10mg | ≥98% | 1337531-06-2 | 10mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
GSK2593074A | G651840-100mg | ≥98% | 1337531-06-2 | 100mg | ¥ 22500.9 | 期货,请咨询 | 阿拉丁 |
Glycolic acid-d2 | G651823-5mg | ≥98% | 75502-10-2 | 5mg | ¥ 1100.9 | 期货,请咨询 | 阿拉丁 |
Glycolic acid-d2 | G651823-1mg | ≥98% | 75502-10-2 | 1mg | ¥ 500.9 | 期货,请咨询 | 阿拉丁 |
Glycolic acid-d2 | G651823-10mg | ≥98% | 75502-10-2 | 10mg | ¥ 1600.9 | 期货,请咨询 | 阿拉丁 |
GSK3494245 | G651772-5mg | ≥98% | 2080410-41-7 | 5mg | ¥ 5100.9 | 期货,请咨询 | 阿拉丁 |
GSK3494245 | G651772-10mg | ≥98% | 2080410-41-7 | 10mg | ¥ 8200.9 | 期货,请咨询 | 阿拉丁 |
GNE-6468 | G651767-5mg | ≥98% | 1677668-27-7 | 5mg | ¥ 4500.9 | 期货,请咨询 | 阿拉丁 |
GNE-6468 | G651767-50mg | ≥98% | 1677668-27-7 | 50mg | ¥ 22500.9 | 期货,请咨询 | 阿拉丁 |
GNE-6468 | G651767-250mg | ≥98% | 1677668-27-7 | 250mg | ¥ 53500.9 | 期货,请咨询 | 阿拉丁 |